Yun Eunji, Ko Hey Jin, Ahn Boryung, Lee Hyejin, Jang Won Mo, Lee Jin Yong
Division of Pharmaceutical Policy Research, HIRA Research Institute, Health Insurance Review & Assessment Service, Wonju-si, Gangwon-do, Republic of Korea.
Division of Healthcare Coverage Research, HIRA Research Institute, Health Insurance Review & Assessment Service, Wonju-si, Gangwon-do, Republic of Korea.
Risk Manag Healthc Policy. 2022 Nov 2;15:2031-2042. doi: 10.2147/RMHP.S375422. eCollection 2022.
South Korea has utilized its National Health Insurance (NHI) system to adjust the medical fees payable for healthcare services, to financially support the frontline healthcare providers combating COVID-19. This study evaluated the composition of such adjustments to the medical fees-made to secure resource surge capacity against the pandemic-in South Korea.
Descriptive statistics and schematization were employed to analyze 3,612,640 COVID-19-related NHI claims from January 1, 2020, to June 30, 2021. COVID-19 suspected and confirmed cases were evaluated based on the proportion of fees adjustment, classified into space, staff, or stuff (3S) using diagnosis codes. The proportion of fees adjustment was investigated in terms of the healthcare expenditure, number of patients, and number of healthcare services covered.
First, in terms of cost, medical fee adjustments covered over 96% of the total costs arising from the increased demand for testing (stuff) and isolated spaces among patients suspected of having COVID-19. Second, medical fees were adjusted to cover over 80% of the cost attributable to COVID-19 confirmed cases, in relation to isolated spaces and medical staff support. Third, the adjustment of less than 10% of the various types of medical fees, if selected strategically, can effectively induce a surge in resource capacity.
South Korea has improved its existing surge capacity by adjusting the medical fees payable through NHI to healthcare providers. Particularly, through the provider payment system of fee-for-service, the Korean government could prevent the spread of infection and protect the medical staff assigned to respond to COVID-19. However, additional studies on alternative payment systems are needed to control costs while maintaining an effective pandemic response system in the face of the prolonged COVID-19 outbreak.
韩国利用其国家健康保险(NHI)系统调整医疗服务应付费用,为抗击新冠疫情的一线医疗服务提供者提供财政支持。本研究评估了韩国为应对疫情确保资源激增能力而进行的此类医疗费用调整的构成。
采用描述性统计和图表法分析了2020年1月1日至2021年6月30日期间3,612,640份与新冠疫情相关的NHI理赔申请。根据费用调整比例对新冠疑似和确诊病例进行评估,使用诊断代码将其分为空间、人员或物资(3S)类别。从医疗支出、患者数量和涵盖的医疗服务数量方面调查费用调整比例。
首先,在成本方面,医疗费用调整覆盖了因对新冠疑似患者检测需求增加(物资)和隔离空间而产生的总成本的96%以上。其次,针对隔离空间和医务人员支持,医疗费用调整覆盖了与新冠确诊病例相关成本的80%以上。第三,如果进行战略性选择,对各类医疗费用不到10%的调整就能有效促使资源能力激增。
韩国通过调整NHI向医疗服务提供者应付的医疗费用,提高了现有的激增能力。特别是,通过按服务收费的提供者支付系统,韩国政府能够防止感染传播并保护被分配应对新冠疫情的医务人员。然而,面对新冠疫情的长期爆发,在维持有效的疫情应对系统的同时控制成本,还需要对替代支付系统进行更多研究。